Lung cancers: molecular characterization, clonal heterogeneity and evolution, and cancer stem cells

U Testa, G Castelli, E Pelosi - Cancers, 2018 - mdpi.com
Lung cancer causes the largest number of cancer-related deaths in the world. Most (85%) of
lung cancers are classified as non-small-cell lung cancer (NSCLC) and small-cell lung …

Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?

AM Bellizzi - Human pathology, 2020 - Elsevier
This review is based on a presentation given at the Hans Popper Hepatopathology Society
companion meeting at the 2019 United States and Canadian Academy of Pathology Annual …

[HTML][HTML] A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization …

G Rindi, DS Klimstra, B Abedi-Ardekani, SL Asa… - Modern Pathology, 2018 - Elsevier
The classification of neuroendocrine neoplasms (NENs) differs between organ systems and
currently causes considerable confusion. A uniform classification framework for NENs at any …

Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites

TL Dayton, N Alcala, L Moonen, L den Hartigh… - Cancer Cell, 2023 - cell.com
Neuroendocrine neoplasms (NENs) comprise well-differentiated neuroendocrine tumors
(NETs) and poorly differentiated neuroendocrine carcinomas (NECs). Treatment options for …

Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

E Baudin, M Caplin, R Garcia-Carbonero… - Annals of …, 2021 - annalsofoncology.org
The latest World Health Organization (WHO) classification from 2015 has grouped lung and
thymic neuroendocrine tumours (NETs)(named neoplasm in the digestive WHO …

[HTML][HTML] Rare pulmonary neuroendocrine cells are stem cells regulated by Rb, p53, and Notch

Y Ouadah, ER Rojas, DP Riordan, S Capostagno… - Cell, 2019 - cell.com
Pulmonary neuroendocrine (NE) cells are neurosensory cells sparsely distributed
throughout the bronchial epithelium, many in innervated clusters of 20–30 cells. Following …

[HTML][HTML] Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications

FZ Marino, R Bianco, M Accardo, A Ronchi… - … journal of medical …, 2019 - ncbi.nlm.nih.gov
Molecular heterogeneity is a frequent event in cancer responsible of several critical issues in
diagnosis and treatment of oncologic patients. Lung tumours are characterized by high …

Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 …

WM Hackeng, LAA Brosens, JY Kim, R O'Sullivan… - Gut, 2022 - gut.bmj.com
Objective Recent studies have found aristaless-related homeobox gene (ARX)/pancreatic
and duodenal homeobox 1 (PDX1), alpha-thalassemia/mental retardation X-linked …

Molecular subtypes of pulmonary large-cell neuroendocrine carcinoma predict chemotherapy treatment outcome

JL Derks, N Leblay, E Thunnissen, RJ Van Suylen… - Clinical Cancer …, 2018 - AACR
Purpose: Previous genomic studies have identified two mutually exclusive molecular
subtypes of large-cell neuroendocrine carcinoma (LCNEC): the RB1 mutated (mostly …

COMPASS Ascending: Emerging clues regarding the roles of MLL3/KMT2C and MLL2/KMT2D proteins in cancer

RJ Fagan, AK Dingwall - Cancer letters, 2019 - Elsevier
The KMT2 (lysine methyltransferase) family of histone modifying proteins play essential
roles in regulating developmental pathways, and mutations in the genes encoding these …